Tag: COSM Stock

  • Cosmos Health (COSM) Stock Sees Massive Surge with Major UAE Deal

    Cosmos Health (COSM) Stock Sees Massive Surge with Major UAE Deal

    Cosmos Health Inc. (NASDAQ: COSM) experienced a remarkable trading day on Thursday, climbing by nearly 5.3%. However, the real excitement unfolded after the closing bell, as the stock skyrocketed by an additional 60% in afterhours trading, driven by bullish investor sentiment.

    Agreement with Pharmalink Boosts Confidence

    The surge followed Cosmos Health’s announcement of an exclusive distribution agreement with Pharmalink for its Sky Premium Life nutraceuticals in the United Arab Emirates (UAE).

    This deal assigns Pharmalink, a major healthcare player in the UAE, the responsibilities of sales, marketing, regulatory affairs, logistics, and distribution of Sky Premium Life products. Pharmalink’s extensive network, which includes 3,000 pharmacies and the MEDICINA chain, positions it well to drive significant market penetration.

    The agreement has already secured an initial order for 130,000 units and anticipates over 500,000 units in the first year, projecting to exceed 3,000,000 units over the next five years.

    Cosmos Background

    Cosmos Health Inc., founded in 2009 and based in Nevada, is a diversified, vertically integrated global healthcare group. The company owns a robust portfolio of pharmaceutical and nutraceutical brands such as Sky Premium Life®, Mediterranation®, bio-bebe®, and C-Sept®.

    Through its subsidiary, Cana Laboratories S.A., Cosmos Health manufactures a wide range of products, including pharmaceuticals, food supplements, and medical devices, all compliant with European Good Manufacturing Practices (GMP). The company distributes pharmaceuticals and OTC medications through its subsidiaries in Greece and the UK and has expanded into telehealth via the acquisition of ZipDoctor, Inc.

    Conclusion

    While the afterhours surge in Cosmos Health’s stock price reflects strong market optimism, some skepticism remains. Critics suggest that the company’s CEO may have used this significant agreement to push the stock above $1, addressing immediate listing concerns.

    However, the agreement with Pharmalink underscores Cosmos Health’s strategic efforts to expand its global footprint, particularly in the lucrative UAE market. As the company continues to grow and secure more substantial orders, its long-term prospects appear promising.

  • On What Basis Did COSM Stock Rise 13% Last Trading?

    Cosmos Holdings Inc (OTCQX: COSM) closed the last session at $5.4200, up 12.92% from its previous close. Pink sheets Cosmos stock has 16.07 million outstanding shares compared to 2.92 million float. A recent update has caused COSM stock to rise despite the absence of current news.

    What was that update about?

    Cosmos Holdings brings together a wide range of pharmaceutical products, nutraceuticals, OTC medications, and medical devices, as well as a longstanding distribution network throughout the EU. With an extensive network of clients in Europe, the Middle East, and the Asia Pacific, COSM identifies, acquires, develops, and commercializes products that improve patients’ lives and outcomes. Thessaloniki, Athens, and Harlow, UK are all home to COSM’s offices and distribution centers.

    A recent update on the company’s business was presented by Cosmos during its Q1 2021 financial report.

    Highlights of business update:

    • Four new products were introduced by COSM, including Bodyguard, Osteodome, King Eros, and Queen Venus.
    • COSM has also introduced Mosept-Oral, a new, proprietary mouthwash that is effective against bacteria, viruses, fungus, and for the symptomatic relief of sore throats.
    • New branded pharmaceutical products and nutraceuticals set to be introduced into the international market in the coming quarters will drive COSM’s revenue growth and profitability.
    • DECAHEDRON LTD, a UK-based supplier of pharmaceutical goods and fulfillment center owned by COSM, recently started selling Sky Premium Life products through Amazon United Kingdom (UK).
    • By the end of this year, COSM expects to have all of its 65 Sky Premium Life SKUs on Amazon UK.
    • In terms of e-commerce and its online global distribution strategy, the Amazon UK initiative represents a significant step forward by COSM.

    How does COSM plan to proceed?

    With its products available on Amazon UK, COSM is expected to experience exponential growth thanks to its robust distribution network. Furthermore, Cosmos (COSM) continues to add distributors around the world as it is planning to enter several new markets in Europe and beyond during the late part of the year.